Legal Representation
Attorney
Ruth E. Freeburg
USPTO Deadlines
Application History
10 eventsDate | Code | Type | Description |
---|---|---|---|
Aug 8, 2008 | ABN1 | O | ABANDONMENT - EXPRESS MAILED |
Aug 8, 2008 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT |
Aug 7, 2008 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Aug 7, 2008 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Aug 7, 2008 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED |
Mar 13, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN |
Mar 13, 2008 | CNRT | F | NON-FINAL ACTION MAILED |
Mar 10, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 7, 2007 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Dec 3, 2007 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 016
Printed publications, namely, brochures and booklets in the field of molecular signatures of tissues, namely DNA, RNA, or proteins within a tumor, prediction of cancer risk, diagnosis, prognosis, and response to therapy; identification of new molecular targets for the development of more effective cancer prevention and personalized treatment programs
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Online publications, namely, brochures and booklets in the field of molecular signatures of tissues, namely DNA, RNA, or proteins within a tumor, prediction of cancer risk, diagnosis, prognosis, and response to therapy; identification of new molecular targets for the development of more effective cancer prevention and personalized treatment programs
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Medical research in the field of molecular signatures of tissues, namely DNA, RNA, or proteins within a tumor, prediction of cancer risk, diagnosis, prognosis, and response to therapy; identification of new molecular targets for the development of more effective cancer prevention and personalized treatment programs
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Providing health care, information and counseling in the field of molecular signatures of tissues, namely DNA, RNA, or proteins within a tumor, providing medical screening and diagnosis services
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a double helix above a group of circles making up a diamond shape to the left of the literal portion of the mark.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
016
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BILL AND BEVERLY YOUNG"